Clinical Trial Update: Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease [NA]

View source ↗

Summary

This clinical trial is recruiting to evaluate the metabolic effects of the Ren-Nu dietary program in autosomal dominant polycystic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Snippet

Sponsor: Richard Fatica | Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) | NA | Status: RECRUITING